Christina Applegate, star of the television comedy “Up All Night,” has talked openly about her experience with breast cancer.

Still, the actress wishes she hadn’t been outed to the world in 2008 before the anesthetic from her mastectomy surgery even wore off.

“The good thing is that we got the information out,” Applegate says in this month’s edition of MORE magazine. “But talking about the facts of the disease, I didn’t have to see what was going on with me. I think when it slowed down, all of that came crashing down.”FULL POST

For more than a decade, studies have shown that some cancer patients benefit from taking aspirin, but who exactly might benefit remained unclear. Now a new study appears to have found a specific patient population that may live longer by taking this drug: Colon cancer patients.

After reviewing data from 964 colorectal cancer patients, researchers at the Dana-Farber Cancer Institute in Boston found when patients whose tumors had a mutated form of the PIK3CA gene took aspirin after being diagnosed, they lived significantly longer than patients without the mutation.

The study is published in the October 25 edition of the New England Journal of Medicine. Ninety-seven percent of patients with this mutation who took aspirin were alive five years after being diagnosed with colon cancer. Only 76% of patients with the mutation who didn't take aspirin were still alive five years later. FULL POST

Get a behind-the-scenes look at the latest stories from CNN Chief Medical Correspondent, Dr. Sanjay Gupta, Senior Medical Correspondent Elizabeth Cohen and the CNN Medical Unit producers. They'll share news and views on health and medical trends - info that will help you take better care of yourself and the people you love.